Please use this identifier to cite or link to this item:
Title: Systemic inflammation and acute-on-chronic liver failure: too much, not enough
Author: Laleman, Wim
Clària i Enrich, Joan
Merwe, Schalk van der
Moreau, Richard
Trebicka, Jonel
Keywords: Inflamació
Malalties del fetge
Cirrosi hepàtica
Liver diseases
Hepatic cirrhosis
Issue Date: 1-Dec-2018
Abstract: ACLF is a specific, but complex and multifactorial form of acute decompensation of cirrhosis and is characterized by an extraordinary dynamic natural course, rapidly evolving organ failure, and high short-term mortality. Dysbalanced immune function is central to its pathogenesis and outcome with an initial excessive systemic inflammatory response that drives organ failure and mortality. Later in its course, immuno-exhaustion/immunoparalysis prevails predisposing the patient to secondary infectious events and reescalation in end-organ dysfunction and mortality. The management of patients with ACLF is still poorly defined. However, as its pathophysiology is gradually being unravelled, potential therapeutic targets emerge that warrant further study such as restoring or substituting albumin via plasma exchange or via albumin dialysis and evaluating usefulness of TLR4 antagonists, modulators of gut dysbiosis (pre- or probiotics), and FXR-agonists.
Note: Reproducció del document publicat a:
It is part of: Canadian Journal Of Gastroenterology And Hepatology, 2018, vol. 2018, p. 1027152
Related resource:
ISSN: 2291-2797
Appears in Collections:Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
687699.pdf1.87 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons